NICHD Neonatal Research Network Search
border Star Spacer Star Spacer Star Spacer Star Spacer Star Spacer Star Spacer Spacer
Image1 - Baby
Image2 - Baby
Spacer
Image3 - Baby

Image - Design

The Maternal Lifestyle Study (MLS)
Section Break
Background

Prenatal substance abuse continues to be a major public health problem affecting millions of children in addition to placing both financial and social burdens on society.

The Maternal Lifestyle Study (MLS) began as an interagency longitudinal study in the early 1990’s specifically against the backdrop of debate and controversy around the effects of prenatal cocaine exposure on child outcomes. Accessing a large multi-site population of newborn infants and their mothers through the NICHD Neonatal Research Network (NRN) allowed an in-depth prospective study of mothers and children exposed in utero to cocaine. The collaborative nature of the NRN also provided access to a multi-cultural, multi-ethnic, socio-demographically varied population in whom widespread use of drugs was previously demonstrated.

Now in its 13th year, the MLS is the largest clinical prospective longitudinal study to date of prenatal drug exposure and child outcome. Conducted at four Neonatal Research Network sites (University of Miami, University of Tennessee at Memphis, Wayne State University, and Brown University), the cohort includes 658 exposed and 730 comparison mother/child dyads.

Section Break
Study Participants

In the first phase of the study, 19,079 pregnant mothers were recruited just before or after they gave birth. Of these, 16,988 (89%) met basic eligibility criteria and 11,811 (70%) of these agreed to participate in the study. Drug use was confirmed by mother interview and gas chromatography/mass spectroscopy (gc/ms) for cocaine/opiate metabolites in the meconium of the infant. Based on this information, there were 1185 (10%) infants who were exposed to either cocaine or opiates during pregnancy. A total of 7442 (63%) of the infants were confirmed to have been exposed to neither cocaine nor opiates. There were 3184 (27%) infants whose exposure status was not confirmed. The use of alcohol, tobacco, marijuana by the mother occurred in all three of these groups.

Phase II of the study tracked the development of infants who had been exposed to illicit drugs, comparing the results to infants whose mothers had not used illicit drugs. A total of 1,388 subjects were recruited into this part of the study. Of these, 658 were infants exposed to either cocaine, opiates or both. There were 730 infants who had been exposed to neither. All of these infants were seen at 1 month of age. Their mothers or caretakers were encouraged to participate in visits at 4, 8, 10, 12, 18, 24, 30, and 36 months of age. At these visits, the children participated in a variety of assessments that noted both their medical and developmental outcomes over time. Mothers and caretakers were also asked questions about the infant and the environment.

Mother/child dyads have continued their involvement in the study through subsequent phases. Phase 3 covered visits of the child from the time he or she was 4 years, up until age 7. In Phase 4 children were seen between the ages of 8 and 11 at yearly clinic visits in addition to intermittent home and school visits. This pattern of clinic, home and school visits continues into Phase V including children between the ages of 12 and 15.

Section Break
Scientific Aims

The MLS continues to study the effects of prenatal cocaine/opiate exposure on immediate child outcomes that start in infancy (e.g. attention, relationship to parent, neuromotor, physiologic reactivity, arousal/regulation, and medical status) as well as latent effects on domains of function that become salient as children reach school age (e.g. cognition, antisocial behavior, substance use onset, psychopathology, neuroendocrine function, and health disorders). This line of research also includes determining the effects of heavy cocaine exposure and controlling for exposure to other drugs (alcohol, marijuana, and tobacco), medical (e.g. physical growth) and environmental factors, gender, minority status, and site.

In addition, the MLS studies how immediate and latent teratogenic drug effect and the effect of postnatal caregiving environment including sociodemographics, caregiving context and caregiver characteristics, combine to influence child outcome. This includes specific aspects of the caregiving environment unique to the drug culture and the role of protective factors. It also includes the study of multiple pathways to latent outcome effects. For example, prenatal exposure may result in behavior and executive function problems that in turn lead to deviance and early onset of substance abuse.

Section Break
Conclusion

It is now well documented that scientific reports in the 1980's were exaggerated and incorrect in their portrayal of children exposed to cocaine in utero as irreparably damaged. Current research does, however, suggest that the effects of cocaine on child development are inconsistent, subtle and need to be understood in the context of polydrug use and the caregiving environment.

As a major longitudinal study, the MLS offers important scientific contributions to the field of developmental research for both normal and at-risk children. In addition, understanding the consequences of prenatal cocaine exposure and its relationship with risky environments provides a crucial framework for making treatment decisions and informing overall public policy.

 

About | Home | Links | Private Gateway
Publications | Studies |  Tools 

Please address technical questions about this web site to NRNTechSupport@rti.org.

©2013 Research Triangle International. All Rights Reserved. RTI International is a trade name of Research Triangle Institute.

 

Spacer